Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed CFO Acq. announced Director departure Quarterly results Appointed director CC transcript
|
ILLUMINA, INC. (ILMN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/11/2022 |
8-K
| Investor presentation |
01/12/2021 |
8-K
| Quarterly results |
01/16/2020 |
8-K
| Investor presentation
Docs:
|
"CORPORATE PARTICIPANTS Francis A. deSouza Illumina, Inc. - President & CEO CONFERENCE CALL PARTICIPANTS Tycho W. Peterson JP Morgan Chase & Co, Research Division - Senior Analyst Sam Samad Illumina, Inc - CFO PRESENTATION Tycho W. Peterson - JP Morgan Chase & Co, Research Division - Senior Analyst Okay. We're going to go ahead and kick it off. Good morning, everybody. Welcome to day 1 of the Healthcare Conference. I'm Tycho Peterson from Life Science Tools Diagnostics team. It's my pleasure to introduce our next company this morning, Illumina. We'll do a breakout right after in the Borgia Room. And with that, let me turn it over to Francis. Francis A. deSouza - Illumina, Inc. - President & CEO Thank you, Tycho and the JPMorgan team for hosting Illumina. Good morning, everyone. Before I sta...",
"Illumina, Inc. Reconciliation of Non-GAAP Financial Guidance The Company’s future performance and financial results are subject to risks and uncertainties, and actual results could differ materially from the guidance set forth below. Potential factors that could affect our financial results are included from time to time in the public reports filed with the Securities and Exchange Commission, including Form 10-K for the fiscal year ended December 30, 2018 filed with the SEC on February 11, 2019, Form 10-Q for the fiscal quarter ended March 31, 2019, Form 10-Q for the fiscal quarter ended June 30, 2019, and Form 10-Q for the fiscal quarter ended September 29, 2019. We assume no obligation to update any forward-looking statements or information. Fiscal Year 2020 GAAP diluted earnings per sha..." |
|
01/11/2017 |
8-K
| Form 8-K - Current report |
|
|